Phase IISmall Molecule
Compound 61525
Formula Pending
Molecular Mass
N/A
CAS Registry
AUTO-061525
Risk Class
LOW
Last Audit
Mar 23, 2108
Research Abstract
Small Molecule candidate engineered for metabolic regulation initiatives with automated dossier coverage.
Compound 61525 is a small molecule asset inside small molecule innovation track initiatives, optimized for metabolic regulation and cardiometabolic recovery.
The dossier currently sits in phase ii with a low risk rating, meaning it is cleared for baseline monitoring protocols.
Supply records cite CAS AUTO-061525 with updates logged 2108-03-23.
Acquisition Protocol
Authorized research personnel may request deployment of this compound for laboratory analysis.
Primary Vectors
Metabolic regulationCardiometabolic recovery
Nomenclature
CX-61525Small Molecule Program 61525
Reference Material
- [1] Anubis Compound Registry • CAS AUTO-061525
- [2] Operations Pulse • Small Molecule innovation track
- [3] Risk Governance Ledger • LOW clearance for COMPOUND-61525